garcinol has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, S; David, D; Geamanu, A; Goja, A; Gupta, SV; Razalli, NH; Saadat, N; Shen, Y | 1 |
| Lao, YZ; Lv, Y; Tan, HS; Wang, J; Wu, M; Xu, HX; Zhang, H; Zhang, L; Zheng, D; Zhou, H | 1 |
| Chiou, LY; Chiou, YS; Ho, CT; Pan, MH; Tsai, ML | 1 |
3 other study(ies) available for garcinol and Experimental Neoplasms
| Article | Year |
|---|---|
Dietary Garcinol Arrests Pancreatic Cancer in p53 and K-ras Conditional Mutant Mouse Model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Deoxycytidine; Dietary Supplements; Gemcitabine; Genes, p53; Genes, ras; Humans; Magnetic Resonance Imaging; Male; Mice, Transgenic; Neoplasms, Experimental; Pancreatic Neoplasms; S100 Calcium Binding Protein beta Subunit; Smad4 Protein; Survival Rate; Terpenes | 2018 |
Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; E1A-Associated p300 Protein; Esophageal Neoplasms; Garcinia; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Signal Transduction; Terpenes; Transforming Growth Factor beta1; Tumor Cells, Cultured; Wound Healing | 2020 |
Garcinol suppresses inflammation-associated colon carcinogenesis in mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; beta Catenin; Colitis; Colonic Neoplasms; Dextran Sulfate; Hepatitis; Inflammation Mediators; Lipid Metabolism; Male; Mice, Inbred ICR; Neoplasms, Experimental; Signal Transduction; Terpenes | 2014 |